NCT00651937
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,662 public trials
323 recruiting studies
Multiple Myeloma trial results
NCT01146834
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- New York University Cancer Institute New York, United States
- Columbia Presbyterian Medical Center): New York, United States
- Memorial Sloan-Kettering Cancer Center): New York, United States
NCT00925782
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Kansas Medical Center/University of Kansas Cancer Center and Medical Pavillion Kansas City, Kansas, United States
Completed
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
NCT02958969
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +15 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT02410694
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Medizinische Universitätsklinik Graz, Klinische Abteilung für Hämatologie Graz, Styria, Austria
- UK Innsbruck, Universitätsklinik für Innere Medizin, Klinische Abteilung für Hämatologie und Onkologie Innsbruck, Tyrol, Austria
- A.ö. BK Kufstein, Abteilung für Innere Medizin Kufstein, Tyrol, Austria
- Ordensklinikum, KH der Barmherzigen Schwestern Linz, Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie Linz, Upper Austria, Austria
Completed
Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma
NCT00581919
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Mercy Health Systems Janesville, Wisconsin, United States
- Gundersen Lutheran La Crosse, Wisconsin, United States
- University of Wisconsin Cancer Center Madison, Wisconsin, United States
- Regional Cancer Center Waukesha/Oconomowoc, Wisconsin, United States
NCT00001623
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +33 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT02057640
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT01352286
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- GSK Investigational Site Baltimore, Maryland, United States
- GSK Investigational Site Philadelphia, Pennsylvania, United States
NCT00866138
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Hopital Saint Louis Paris, France